1. Home
  2. NRDY vs SCLX Comparison

NRDY vs SCLX Comparison

Compare NRDY & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRDY
  • SCLX
  • Stock Information
  • Founded
  • NRDY 2007
  • SCLX 2011
  • Country
  • NRDY United States
  • SCLX United States
  • Employees
  • NRDY N/A
  • SCLX 113
  • Industry
  • NRDY Computer Software: Prepackaged Software
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRDY Technology
  • SCLX Health Care
  • Exchange
  • NRDY Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • NRDY 110.3M
  • SCLX 81.7M
  • IPO Year
  • NRDY N/A
  • SCLX N/A
  • Fundamental
  • Price
  • NRDY $0.96
  • SCLX $0.61
  • Analyst Decision
  • NRDY Hold
  • SCLX Strong Buy
  • Analyst Count
  • NRDY 8
  • SCLX 3
  • Target Price
  • NRDY $2.35
  • SCLX $11.33
  • AVG Volume (30 Days)
  • NRDY 1.8M
  • SCLX 184.3K
  • Earning Date
  • NRDY 11-07-2024
  • SCLX 11-26-2024
  • Dividend Yield
  • NRDY N/A
  • SCLX N/A
  • EPS Growth
  • NRDY N/A
  • SCLX N/A
  • EPS
  • NRDY N/A
  • SCLX N/A
  • Revenue
  • NRDY $197,325,000.00
  • SCLX $50,833,000.00
  • Revenue This Year
  • NRDY $4.56
  • SCLX $32.77
  • Revenue Next Year
  • NRDY $14.87
  • SCLX $50.71
  • P/E Ratio
  • NRDY N/A
  • SCLX N/A
  • Revenue Growth
  • NRDY 9.55
  • SCLX 9.41
  • 52 Week Low
  • NRDY $0.73
  • SCLX $0.54
  • 52 Week High
  • NRDY $3.60
  • SCLX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • NRDY 53.51
  • SCLX 28.71
  • Support Level
  • NRDY $0.79
  • SCLX $0.73
  • Resistance Level
  • NRDY $0.94
  • SCLX $1.14
  • Average True Range (ATR)
  • NRDY 0.09
  • SCLX 0.11
  • MACD
  • NRDY 0.00
  • SCLX -0.04
  • Stochastic Oscillator
  • NRDY 88.64
  • SCLX 11.99

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its purpose-built proprietary platform leverages technology, including AI, to connect learners of all ages to experts, delivering superior value on both sides of the network. Its comprehensive learning destination provides learning experiences across various subjects and multiple formats including one-on-one instruction, small group classes, large format group classes, and adaptive self-study.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: